Rejuvenation Technologies

About:

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.

Website: https://www.rejuvenationtech.com/

Top Investors: Khosla Ventures, Y Combinator, Lifespan Vision Ventures, Asymmetry Ventures, Reinforced Ventures

Description:

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

Total Funding Amount:

$15.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mountain View, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)rejuvenationtech.com

Founders:

Glenn Markov, John Ramunas

Number of Employees:

1-10

Last Funding Date:

2023-10-11

IPO Status:

Private

Industries: